because of the iatrogenic morbidity , mortality and high cost of the supportive care required during the post-transplantation period of prolonged marrow aplasia , intensive therapy remains a sophisticated procedure lacking proper evaluation in clinical trials .
C0184661
procedure
C0220825
evaluation